COMPANY · NIPC 500139962

GLAXO SMITHKLINE- PROD.FARMAC., LDA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €466,832,734.08 across 5,489 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameGLAXO SMITHKLINE- PROD.FARMAC., LDA
NIPC500139962
Registered officeR. ANT. LOUREIRO BORGES, N. 3, 1495-131 ALGÉS
SourceTED (Jornal Oficial da UE), aviso 773365-2024
Record date17 December 2024

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €5,391,498.9020122013: €7,656,475.602014: €39,778,061.1720142015: €51,906,346.472016: €3,852,442.3320162017: €9,204,693.312018: €9,272,690.2720182019: €16,127,010.792020: €22,923,804.5920202021: €45,499,310.552022: €34,812,349.0220222023: €36,130,916.132024: €53,803,537.9420242025: €65,186,815.172026: €65,286,781.842026€65,286,781.84
Contracted value by year
YearContractsContract value
201282€5,391,498.90
2013129€7,656,475.60
2014274€39,778,061.17
2015204€51,906,346.47
2016161€3,852,442.33
2017223€9,204,693.31
2018228€9,272,690.27
2019296€16,127,010.79
2020379€22,923,804.59
2021469€45,499,310.55
2022483€34,812,349.02
2023603€36,130,916.13
2024632€53,803,537.94
2025758€65,186,815.17
2026568€65,286,781.84
Contracted value by place of performance
NameContractsContract value
Coimbra247€82,979,563.99
Lisboa861€64,101,372.05
Faro303€40,573,865.91
Vila Real100€37,283,275.72
Maia87€36,831,570.45
Porto420€23,748,768.92
Setúbal222€23,472,331.71
Évora108€18,245,586.20
Funchal119€10,739,799.90
Amadora106€8,674,367.97
Largest contracts
SubjectYearContract value
Medicamentos do foro oncológico - com base no CPA 2013/62015€31,589,591.37
Medicamentos anti-infecciosos, anti-retrovirais2014€11,663,507.38
P259-2021-027 - Aquisição de vacinas e tuberculinas para cumprimento do Programa Nacional de Vacinação 2021 para as Instituições do SNS2021€5,092,639.16
P259-2020-101 - Aquisição de Vacinas e Tuberculinas para Instituições do SNS2020€5,076,226.56
P259-2020-101 - Aquisição de Vacinas e Tuberculinas para Instituições do SNS2020€4,754,640

Who they competed with

In 11,532 contracts with a list of competitors, the company took part and was awarded 1,803 (16%).

Companies with the most procedures in common
CompanyProcedures in common
generis715
mylan520
farmoz483
overpharma475
medinfar465
sandoz460
labesfal,, SA440
hikma lda394
pfizer363
fresenius kabi356
accord healthcare unipessoal, lda351
teva pharma347
msd318
Logifarma - Logística Farmacêutica, S.A277
novartis260
braun250
Normon, SA235
unilfarma204
dla sa195
roche farmaceutica166
sanofi prod. farmacêuticos164
Logística,Transp.,Transitários e Pharma,Unipessoal,Lda164
Bluepharma, S.A.160
pharmakern portugal148
Laboratórios Atral,S.A.145
tecnifar135
edol132
angelini127
sidefarma lda127
astrazeneca127

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents37 companies and 60 links. The list below gives the same content as text.novartis (NIPC 500063524)novartissanofi prod. f… (NIPC 500134960)sanofi prod. f…GLAXO SMITHKLINE- PROD.FA… (NIPC 500139962)GLAXO SMITHKLINE- PROD.FA…pfizer (NIPC 500162166)pfizermsd (NIPC 500191360)msdroche farmaceu… (NIPC 500233810)roche farmaceu…unilfarma (NIPC 500293023)unilfarmamedinfar (NIPC 500384045)medinfarangelini (NIPC 500583650)angelinilabesfal,, SA (NIPC 501169580)labesfal,, SAfarmoz (NIPC 501505334)farmoz+26 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.